Show simple item record

dc.contributor.authorHarrington, KJ
dc.date.accessioned2019-02-04T14:17:05Z
dc.date.issued2019-01
dc.identifier.citationClinical cancer research : an official journal of the American Association for Cancer Research, 2019, 25 (1), pp. 3 - 5
dc.identifier.issn1078-0432
dc.identifier.urihttps://repository.icr.ac.uk/handle/internal/3042
dc.identifier.eissn1557-3265
dc.identifier.doi10.1158/1078-0432.ccr-18-1796
dc.description.abstractA new way of delivering radiotherapy at very high dose rates is described and compared with conventional radiotherapy. The ultrahigh dose-rate therapy reduces damage to normal pig skin and exerts potent activity against spontaneous nasal tumors in cat patients. The implications for clinical development of this approach are discussed. See related article by Vozenin et al., p. 35 .
dc.formatPrint-Electronic
dc.format.extent3 - 5
dc.languageeng
dc.language.isoeng
dc.rights.urihttps://www.rioxx.net/licenses/under-embargo-all-rights-reserved
dc.subjectAnimals
dc.subjectSwine
dc.subjectSwine, Miniature
dc.subjectCats
dc.subjectHumans
dc.subjectNeoplasms
dc.subjectRadiotherapy Dosage
dc.titleUltrahigh Dose-rate Radiotherapy: Next Steps for FLASH-RT.
dc.typeJournal Article
dcterms.dateAccepted2018-08-06
rioxxterms.versionofrecord10.1158/1078-0432.ccr-18-1796
rioxxterms.licenseref.urihttps://www.rioxx.net/licenses/under-embargo-all-rights-reserved
rioxxterms.licenseref.startdate2019-01
rioxxterms.typeJournal Article/Review
dc.relation.isPartOfClinical cancer research : an official journal of the American Association for Cancer Research
pubs.issue1
pubs.notesNot known
pubs.organisational-group/ICR
pubs.organisational-group/ICR/Primary Group
pubs.organisational-group/ICR/Primary Group/ICR Divisions
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Cancer Biology
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Cancer Biology/Targeted Therapy
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Radiotherapy and Imaging
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Radiotherapy and Imaging/Targeted Therapy
pubs.organisational-group/ICR
pubs.organisational-group/ICR/Primary Group
pubs.organisational-group/ICR/Primary Group/ICR Divisions
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Cancer Biology
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Cancer Biology/Targeted Therapy
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Radiotherapy and Imaging
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Radiotherapy and Imaging/Targeted Therapy
pubs.publication-statusPublished
pubs.volume25
pubs.embargo.termsNot known
icr.researchteamTargeted Therapyen_US
dc.contributor.icrauthorHarrington, Kevinen


Files in this item

Thumbnail

This item appears in the following collection(s)

Show simple item record